dc.creator | Farsalinos K., Niaura R., Le Houezec J., Barbouni A., Tsatsakis A., Kouretas D., Vantarakis A., Poulas K. | en |
dc.date.accessioned | 2023-01-31T07:37:40Z | |
dc.date.available | 2023-01-31T07:37:40Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1016/j.toxrep.2020.04.012 | |
dc.identifier.issn | 22147500 | |
dc.identifier.uri | http://hdl.handle.net/11615/71475 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | Toxicology Reports | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085278464&doi=10.1016%2fj.toxrep.2020.04.012&partnerID=40&md5=3f8291a659e44cff8bd58fd0978c86fd | |
dc.subject | angiotensin converting enzyme 2 | en |
dc.subject | diuretic agent | en |
dc.subject | interleukin 17 | en |
dc.subject | interleukin 6 | en |
dc.subject | nicotine | en |
dc.subject | nicotinic receptor | en |
dc.subject | nitric oxide | en |
dc.subject | toll like receptor 4 | en |
dc.subject | tumor necrosis factor | en |
dc.subject | 2009 H1N1 influenza | en |
dc.subject | antiinflammatory activity | en |
dc.subject | blood vessel permeability | en |
dc.subject | cholinergic system | en |
dc.subject | chronic obstructive lung disease | en |
dc.subject | coronavirus disease 2019 | en |
dc.subject | cytokine production | en |
dc.subject | cytokine storm | en |
dc.subject | Editorial | en |
dc.subject | fever | en |
dc.subject | homeostasis | en |
dc.subject | human | en |
dc.subject | immune response | en |
dc.subject | infection control | en |
dc.subject | inflammation | en |
dc.subject | inflammatory bowel disease | en |
dc.subject | macrophage activation syndrome | en |
dc.subject | nicotinic cholinergic system | en |
dc.subject | olfactory bulb | en |
dc.subject | Parkinson disease | en |
dc.subject | prevalence | en |
dc.subject | priority journal | en |
dc.subject | risk factor | en |
dc.subject | sepsis | en |
dc.subject | sequence alignment | en |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | en |
dc.subject | upregulation | en |
dc.subject | venous thromboembolism | en |
dc.subject | Elsevier Inc. | en |
dc.title | Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system | en |
dc.type | other | en |